Vitamin D deficiency in elderly people.

Por Nagant de Deuxchaisnes, C, Devogelaer, J P
Publicado em 1991

Bone mineral density in Addison's disease: evidence for an effect of adrenal androgens on bone mass.

Por Devogelaer, J P, Crabbé, J, Nagant de Deuxchaisnes, C
Publicado em 1987

Bone mineral density in Addison's disease.

Por Devogelaer, J P, Crabbé, J, Nagant de Deuxchaisnes, C
Publicado em 1987

Long term follow up of untreated primary hyperparathyroidism.

Por Nagant de Deuxchaisnes, C, Devogelaer, J P, Huaux, J P
Publicado em 1985

Strontium ranelate reduces the risk of vertebral fracture in young postmenopausal women with severe osteoporosis

Por Roux, C, Fechtenbaum, J, Kolta, S, Isaia, G, Andia, J B Cannata, Devogelaer, J-P
Publicado em 2008

Intranasal calcitonin and plasma calcium concentrations.

Por Nagant de Deuxchaisnes, C, Devogelaer, J P, Huaux, J P, Dufour, J P, Esselinckx, W
Publicado em 1985

Non-hormonal treatment of osteoporosis

Por de Deuxchaisnes, C Nagant, Devogelaer, J P, Esselinckx, W, Depresseux, G, Rombouts-Lindemans, C, Huaux, J P
Publicado em 1983

IL-12 inhibits in vitro immunoglobulin production by human lupus peripheral blood mononuclear cells (PBMC)

Por HOUSSIAU, F A, MASCART-LEMONE, F, STEVENS, M, LIBIN, M, DEVOGELAER, J-P, GOLDMAN, M, RENAULD, J-C
Publicado em 1997

Loading and Skeletal Development and Maintenance

Por Bergmann, P., Body, J. J., Boonen, S., Boutsen, Y., Devogelaer, J. P., Goemaere, S., Kaufman, J., Reginster, J. Y., Rozenberg, S.
Publicado em 2010

Evidence-based guidelines for the pharmacological treatment of postmenopausal osteoporosis: a consensus document by the Belgian Bone Club

Por Body, J.-J., Bergmann, P., Boonen, S., Boutsen, Y., Devogelaer, J.-P., Goemaere, S., Kaufman, J.-M., Rozenberg, S., Reginster, J.-Y.
Publicado em 2010

Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications

Por Body, J.-J., Bergmann, P., Boonen, S., Devogelaer, J.-P., Gielen, E., Goemaere, S., Kaufman, J.-M., Rozenberg, S., Reginster, J.-Y.
Publicado em 2012

FLUORIDE EFFECTS ON BONE FORMATION AND MINERALIZATION ARE INFLUENCED BY GENETICS

Por Mousny, M., Omelon, S., Wise, L., Everett, E. T., Dumitriu, M., Holmyard, D. P., Banse, X., Devogelaer, J. P., Grynpas, M. D
Publicado em 2008

Evidence-based guidelines for the use of biochemical markers of bone turnover in the selection and monitoring of bisphosphonate treatment in osteoporosis: a consensus document of t...

Por Bergmann, P, Body, J-J, Boonen, S, Boutsen, Y, Devogelaer, J-P, Goemaere, S, Kaufman, J-M, Reginster, J-Y, Gangji, V
Publicado em 2009

Paget's disease of bone.

Por Nagant de Deuxchaisnes, C, Rombouts-Lindemans, C, Huaux, J P, Devogelaer, J P, Malghem, J, Maldague, B, Withofs, H, Meersseman, F
Publicado em 1982

Non-pharmacological management of osteoporosis: a consensus of the Belgian Bone Club

Por Body, J.-J., Bergmann, P., Boonen, S., Boutsen, Y., Bruyere, O., Devogelaer, J.-P., Goemaere, S., Hollevoet, N., Kaufman, J.-M., Milisen, K., Rozenberg, S., Reginster, J.-Y.
Publicado em 2011

Maintenance of antifracture efficacy over 10 years with strontium ranelate in postmenopausal osteoporosis

Por Reginster, J-Y., Kaufman, J-M., Goemaere, S., Devogelaer, J. P., Benhamou, C. L., Felsenberg, D., Diaz-Curiel, M., Brandi, M-L., Badurski, J., Wark, J., Balogh, A., Bruyère, O., Roux, C.
Publicado em 2011

Treatment of osteoporosis in men

Por Kaufman, J.-M., Reginster, J.-Y., Boonen, S., Brandi, M. L., Cooper, C., Dere, W., Devogelaer, J.-P., Diez-Perez, A., Kanis, J. A., McCloskey, E., Mitlak, B., Orwoll, E., Ringe, J.D., Weryha, G., Rizzoli, R.
Publicado em 2012